CAR- T and mobile genetics therapies are actually as well expensive

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care manufacturing and innovation transfer can deliver cell genetics therapies at an inexpensive cost to patients all over the world.